Yi Hsu Huang
Director/Board Member bei ADVAGENE BIOPHARMA CO., LTD.
Profil
Yi Hsu Huang was the founder of Mycenax Biotech, Inc. founded in 2001, where he held the title of Director from 2013 to 2019.
Currently, he is the Chief Executive Officer-Bioproduction Plant at National Health Research Institutes and a Director at Advagene Biopharma Co., Ltd.
since 2016.
He previously worked as the Chief Technology Officer & Deputy General Manager at Medigen Vaccine Biologics Corp.
Dr. Huang holds a doctorate degree from Auburn University and a graduate degree from Northwestern State University.
Aktive Positionen von Yi Hsu Huang
| Unternehmen | Position | Beginn |
|---|---|---|
| ADVAGENE BIOPHARMA CO., LTD. | Director/Board Member | 06.04.2016 |
| National Health Research Institutes | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Yi Hsu Huang
| Unternehmen | Position | Ende |
|---|---|---|
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Chief Tech/Sci/R&D Officer | 01.05.2021 |
| MYCENAX BIOTECH INC. | Founder | 15.08.2019 |
Ausbildung von Yi Hsu Huang
| Auburn University | Doctorate Degree |
| Northwestern State University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MYCENAX BIOTECH INC. | Health Technology |
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Health Technology |
| ADVAGENE BIOPHARMA CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
| National Health Research Institutes |
